S&P 500   5,110.37 (+0.46%)
DOW   39,199.10 (+0.33%)
QQQ   440.31 (+0.51%)
AAPL   184.59 (+0.12%)
MSFT   415.33 (+0.89%)
META   492.63 (+1.34%)
GOOGL   144.31 (+0.15%)
AMZN   174.75 (+0.10%)
TSLA   196.92 (-0.25%)
NVDA   818.59 (+4.23%)
NIO   5.59 (-4.44%)
AMD   183.08 (+0.67%)
BABA   76.52 (+0.53%)
T   16.57 (-0.12%)
F   12.12 (-0.16%)
MU   86.63 (+0.84%)
CGC   3.31 (-1.78%)
GE   152.89 (+0.80%)
DIS   107.50 (-0.13%)
AMC   4.36 (-1.36%)
PFE   27.75 (+0.73%)
PYPL   59.12 (+1.32%)
XOM   103.49 (-1.21%)
S&P 500   5,110.37 (+0.46%)
DOW   39,199.10 (+0.33%)
QQQ   440.31 (+0.51%)
AAPL   184.59 (+0.12%)
MSFT   415.33 (+0.89%)
META   492.63 (+1.34%)
GOOGL   144.31 (+0.15%)
AMZN   174.75 (+0.10%)
TSLA   196.92 (-0.25%)
NVDA   818.59 (+4.23%)
NIO   5.59 (-4.44%)
AMD   183.08 (+0.67%)
BABA   76.52 (+0.53%)
T   16.57 (-0.12%)
F   12.12 (-0.16%)
MU   86.63 (+0.84%)
CGC   3.31 (-1.78%)
GE   152.89 (+0.80%)
DIS   107.50 (-0.13%)
AMC   4.36 (-1.36%)
PFE   27.75 (+0.73%)
PYPL   59.12 (+1.32%)
XOM   103.49 (-1.21%)
S&P 500   5,110.37 (+0.46%)
DOW   39,199.10 (+0.33%)
QQQ   440.31 (+0.51%)
AAPL   184.59 (+0.12%)
MSFT   415.33 (+0.89%)
META   492.63 (+1.34%)
GOOGL   144.31 (+0.15%)
AMZN   174.75 (+0.10%)
TSLA   196.92 (-0.25%)
NVDA   818.59 (+4.23%)
NIO   5.59 (-4.44%)
AMD   183.08 (+0.67%)
BABA   76.52 (+0.53%)
T   16.57 (-0.12%)
F   12.12 (-0.16%)
MU   86.63 (+0.84%)
CGC   3.31 (-1.78%)
GE   152.89 (+0.80%)
DIS   107.50 (-0.13%)
AMC   4.36 (-1.36%)
PFE   27.75 (+0.73%)
PYPL   59.12 (+1.32%)
XOM   103.49 (-1.21%)
S&P 500   5,110.37 (+0.46%)
DOW   39,199.10 (+0.33%)
QQQ   440.31 (+0.51%)
AAPL   184.59 (+0.12%)
MSFT   415.33 (+0.89%)
META   492.63 (+1.34%)
GOOGL   144.31 (+0.15%)
AMZN   174.75 (+0.10%)
TSLA   196.92 (-0.25%)
NVDA   818.59 (+4.23%)
NIO   5.59 (-4.44%)
AMD   183.08 (+0.67%)
BABA   76.52 (+0.53%)
T   16.57 (-0.12%)
F   12.12 (-0.16%)
MU   86.63 (+0.84%)
CGC   3.31 (-1.78%)
GE   152.89 (+0.80%)
DIS   107.50 (-0.13%)
AMC   4.36 (-1.36%)
PFE   27.75 (+0.73%)
PYPL   59.12 (+1.32%)
XOM   103.49 (-1.21%)

Agile Therapeutics (AGRX) Short Interest Ratio & Short Volume

$0.93
-0.02 (-1.84%)
(As of 09:34 AM ET)

Agile Therapeutics Short Interest Data

Current Short Volume
189,900 shares
Previous Short Volume
82,600 shares
Change Vs. Previous Month
+129.90%
Dollar Volume Sold Short
$290,547.00
Short Interest Ratio / Days to Cover
2.8
Last Record Date
January 31, 2024
Outstanding Shares
2,960,000 shares
Float Size
2,830,000 shares
Short Percent of Float
6.71%
Today's Trading Volume
193,050 shares
Average Trading Volume
494,647 shares
Today's Volume Vs. Average
39%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Agile Therapeutics ?

Sign up to receive the latest short interest report for Agile Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

AGRX Short Interest Over Time

AGRX Days to Cover Over Time

AGRX Percentage of Float Shorted Over Time


Agile Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/2024189,900 shares $290,547.00 +129.9%6.7%2.8 $1.53
1/15/202482,600 shares $154,462.00 +287.8%3.4%1.3 $1.87
12/31/202321,300 shares $41,535.00 +156.6%0.9%0.4 $1.95
12/15/20238,300 shares $16,766.00 +23.9%0.4%0.2 $2.02
11/30/20236,700 shares $13,869.00 -62.8%0.3%0.2 $2.07
11/15/202318,000 shares $40,140.00 +12.5%0.8%0.4 $2.23
10/31/202316,000 shares $28,960.00 +263.6%0.9%0.4 $1.81
10/15/20234,400 shares $7,832.00 -76.5%0.2%0.1 $1.78
9/30/202318,700 shares $44,880.00 +567.9%1.0%0.4 $2.40
9/15/20232,800 shares $5,852.00 -73.8%0.2%0.1 $2.09
8/31/202310,700 shares $27,820.00 -48.3%0.6%0.1 $2.60
8/15/202320,700 shares $45,126.00 -46.2%1.1%0.2 $2.18
7/31/202338,500 shares $111,650.00 -45.8%1.4%0.3 $2.90
7/15/202371,000 shares $202,350.00 -42.5%2.5%0.6 $2.85
6/30/2023123,400 shares $364,030.00 -36.7%4.4%1.1 $2.95
6/15/2023194,800 shares $633,100.00 +146.3%6.7%1.9 $3.25
5/31/202379,100 shares $299,789.00 +16.5%2.7%2.8 $3.79
5/15/202367,900 shares $322,525.00 +46.0%6.9%2.6 $4.75
4/30/202346,500 shares $299,925.00 +37.6%5.3%2.4 $6.45
4/15/202333,800 shares $235,924.00 +350.7%3.8%1.8 $6.98
3/31/20237,500 shares $1,680.00 -96.7%0.9%0.4 $0.22
3/15/2023225,700 shares $48,818.91 -39.7%0.6%0.3 $0.22
2/28/2023374,400 shares $89,818.56 -28.7%1.0%0.5 $0.24
2/15/2023524,900 shares $152,221.00 -25.0%1.3%0.7 $0.29
1/31/2023699,500 shares $188,865.00 +2.5%1.8%0.8 $0.27
1/15/2023682,600 shares $197,954.00 -0.1%1.7%0.8 $0.29
12/30/2022683,200 shares $155,086.40 -0.1%1.7%0.8 $0.23
12/15/2022684,100 shares $132,715.40 -18.7%1.7%0.8 $0.19
11/30/2022841,200 shares $176,652.00 -22.8%2.1%0.8 $0.21
11/15/20221,090,000 shares $253,207.00 -31.0%2.8%0.9 $0.23
10/31/20221,580,000 shares $440,820.00 +29.5%4.2%0.8 $0.28
10/15/20221,220,000 shares $318,786.00 -2.4%3.2%0.5 $0.26
9/30/20221,250,000 shares $371,125.00 -15.0%3.3%0.3 $0.30
9/15/20221,470,000 shares $588,000.00 -6.4%3.9%0.1 $0.40
8/31/20221,570,000 shares $631,925.00 -19.5%4.1%0.1 $0.40
8/15/20221,950,000 shares $1.05 million +42.3%5.1%0.2 $0.54
7/31/20221,370,000 shares $699,933.00 +77.4%3.6%0.1 $0.51
7/15/2022772,200 shares $427,026.60 -73.7%2.0%0.1 $0.55
6/30/20222,940,000 shares $3.43 million +510.5%7.8%0.3 $1.17
6/15/2022481,600 shares $587,552.00 -4.2%10.9%1 $1.22













AGRX Short Interest - Frequently Asked Questions

What is Agile Therapeutics' current short interest?

Short interest is the volume of Agile Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 189,900 shares of AGRX short. 6.71% of Agile Therapeutics' shares are currently sold short. Learn More on Agile Therapeutics' current short interest.

What is a good short interest ratio for Agile Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AGRX shares currently have a short interest ratio of 3.0. Learn More on Agile Therapeutics's short interest ratio.

Which institutional investors are shorting Agile Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Agile Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Agile Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.71% of Agile Therapeutics' floating shares are currently sold short.

Is Agile Therapeutics' short interest increasing or decreasing?

Agile Therapeutics saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 189,900 shares, an increase of 129.9% from the previous total of 82,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Agile Therapeutics' float size?

Agile Therapeutics currently has issued a total of 2,960,000 shares. Some of Agile Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Agile Therapeutics currently has a public float of 2,830,000 shares.

How does Agile Therapeutics' short interest compare to its competitors?

6.71% of Agile Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Agile Therapeutics: LumiraDx Limited (2.89%), Virpax Pharmaceuticals, Inc. (0.82%), Processa Pharmaceuticals, Inc. (12.47%), Ensysce Biosciences, Inc. (23.32%), Altamira Therapeutics Ltd. (4.43%), Aravive, Inc. (1.81%), PainReform Ltd. (0.27%), Onconetix, Inc. (7.12%), Petros Pharmaceuticals, Inc. (18.79%), NeuBase Therapeutics, Inc. (0.42%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Agile Therapeutics stock?

Short selling AGRX is an investing strategy that aims to generate trading profit from Agile Therapeutics as its price is falling. AGRX shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Agile Therapeutics?

A short squeeze for Agile Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AGRX, which in turn drives the price of the stock up even further.

How often is Agile Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AGRX, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:AGRX) was last updated on 2/23/2024 by MarketBeat.com Staff